Dashboard
Manage Tickers

MRKMerck & Co., Inc.

NYSE merck.com


$ 115.14 $ 1.38 (1.21 %)    

Friday, 02-Aug-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 447.95 $ -10.91 (-2.37 %)
DIA $ 397.31 $ -6.10 (-1.51 %)
SPY $ 532.92 $ -10.11 (-1.86 %)
TLT $ 98.17 $ 2.97 (3.12 %)
GLD $ 225.36 $ -0.43 (-0.19 %)
$ 115.2
$ 115.13 x 100
$ 115.18 x 100
-- - --
$ 97.23 - $ 134.63
16,562,288
na
291.78B
$ 0.33
$ 126.53
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-03-2024 03-31-2024 10-Q
2 02-26-2024 12-31-2023 10-K
3 11-03-2023 09-30-2023 10-Q
4 08-07-2023 06-30-2023 10-Q
5 05-05-2023 03-31-2023 10-Q
6 02-24-2023 12-31-2022 10-K
7 11-03-2022 09-30-2022 10-Q
8 08-04-2022 06-30-2022 10-Q
9 05-05-2022 03-31-2022 10-Q
10 02-25-2022 12-31-2021 10-K
11 11-05-2021 09-30-2021 10-Q
12 08-09-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-25-2021 12-31-2020 10-K
15 11-05-2020 09-30-2020 10-Q
16 08-05-2020 06-30-2020 10-Q
17 05-06-2020 03-31-2020 10-Q
18 02-26-2020 12-31-2019 10-K
19 11-05-2019 09-30-2019 10-Q
20 08-06-2019 06-30-2019 10-Q
21 05-08-2019 03-31-2019 10-Q
22 02-27-2019 12-31-2018 10-K
23 11-06-2018 09-30-2018 10-Q
24 08-07-2018 06-30-2018 10-Q
25 05-08-2018 03-31-2018 10-Q
26 02-27-2018 12-31-2017 10-K
27 11-07-2017 09-30-2017 10-Q
28 08-08-2017 06-30-2017 10-Q
29 05-09-2017 03-31-2017 10-Q
30 02-28-2017 12-31-2016 10-K
31 11-07-2016 09-30-2016 10-Q
32 08-08-2016 06-30-2016 10-Q
33 05-09-2016 03-31-2016 10-Q
34 02-26-2016 12-31-2015 10-K
35 11-05-2015 09-30-2015 10-Q
36 08-06-2015 06-30-2015 10-Q
37 05-07-2015 03-31-2015 10-Q
38 02-27-2015 12-31-2014 10-K
39 11-10-2014 09-30-2014 10-Q
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

microstrategy-intel-and-moderna-are-among-top-12-large-cap-losers-last-week-july-28-august-3-are-the-others-in-your-portfolio
MicroStrategy, Intel And Moderna Are Among...
08/04/2024 15:20:40

12 worst-performing large-cap stocks in the last week. Symbotic, Intel, Snap, Moderna, Mobileye, Pinterest, Arm, Entegris, Atla...

moderna-stock-trading-lower-on-dismal-guidance-analysts-cuts-price-targets-noting-competitive-pressure-from-gsk-pfizer
Moderna Stock Trading Lower On Dismal Guid...
08/02/2024 18:22:50

Moderna cuts its 2024 sales forecast due to weaker demand for COVID-19 vaccines. Sales now expected between $3B-$3.5B, down fro...

cathie-woods-ark-adds-over-19m-worth-of-moderna-shares-after-thursdays-21-plunge-on-guidance-cut
Cathie Wood's Ark Adds Over $19M Worth Of ...
08/02/2024 13:00:13

Moderna's vaccine magic is slowly losing its charm, as evidenced by the warning the company issued on Thursday but Ark repo...

decoding-merck--cos-options-activity-whats-the-big-picture
Decoding Merck & Co's Options Activity: Wh...
08/01/2024 18:32:56

top-3-health-care-stocks-that-are-set-to-fly-this-quarter
Top 3 Health Care Stocks That Are Set To F...
08/01/2024 13:16:41

daiichi-sankyo-and-merck-announce-first-patient-dosed-in-phase-3-ideate-lung02-trial-evaluating-ifinatamab-deruxtecan-for-relapsed-small-cell-lung-cancer-versus-chemotherapy
Daiichi Sankyo And Merck Announce First Pa...
08/01/2024 12:05:28

barclays-maintains-overweight-on-merck--co-lowers-price-target-to-142
Barclays Maintains Overweight on Merck & C...
07/31/2024 19:08:10

Barclays analyst Carter Gould maintains Merck & Co (NYSE:MRK) with a Overweight and lowers the price target from $145 to...

merck-analysts-slash-their-forecasts-after-q2-results
Merck Analysts Slash Their Forecasts After...
07/31/2024 18:14:32

b-of-a-securities-maintains-buy-on-merck--co-lowers-price-target-to-145
B of A Securities Maintains Buy on Merck &...
07/31/2024 17:24:11

B of A Securities analyst Geoff Meacham maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $150...

wells-fargo-maintains-equal-weight-on-merck--co-lowers-price-target-to-125
Wells Fargo Maintains Equal-Weight on Merc...
07/31/2024 16:07:06

Wells Fargo analyst Mohit Bansal maintains Merck & Co (NYSE:MRK) with a Equal-Weight and lowers the price target from $1...

ubs-maintains-buy-on-merck--co-lowers-price-target-to-142
UBS Maintains Buy on Merck & Co, Lowers Pr...
07/31/2024 15:46:34

UBS analyst Colin Bristow maintains Merck & Co (NYSE:MRK) with a Buy and lowers the price target from $148 to $142.

analyzing-merck-amp-co-in-comparison-to-competitors-in-pharmaceuticals-industry
Analyzing Merck & Co In Comparison To ...
07/31/2024 15:00:37

nasdaq-tumbles-as-microsoft-nvidia-and-other-tech-stocks-decline-greed-index-moves-to-fear-zone
Nasdaq Tumbles As Microsoft, Nvidia And Ot...
07/31/2024 06:50:09

Market sentiment declines as Fear & Greed index moves to 'Fear' zone. Dow Jones gains ahead of major earnings and F...

bristol-myers-johnson--johnson-abbvie-astrazeneca-expect-minimal-impact-from-upcoming-medicare-price-negotiations
Bristol Myers, Johnson & Johnson, AbbVie, ...
07/30/2024 18:12:15

Top pharmaceutical companies including Bristol Myers, Johnson & Johnson, AbbVie, and AstraZeneca foresee limited impact fro...

why-merck-shares-are-trading-lower-by-10-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Merck Shares Are Trading Lower By 10%?...
07/30/2024 17:53:26

tech-stocks-drop-ahead-of-key-earnings-nvidia-falls-crowdstrike-hits-8-month-low-whats-driving-markets-tuesday
Tech Stocks Drop Ahead Of Key Earnings; Nv...
07/30/2024 17:42:51

Investor sentiment took a hit on Tuesday as caution prevailed ahead of significant market events, including key tech earnings r...

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
07/30/2024 17:35:22

pfizer-records-first-sales-growth-in-its-post-covid-era-and-it-owes-it-to-cancer
Pfizer Records First Sales Growth In Its P...
07/30/2024 16:09:06

The market for vaccines and treatments used in managing COVID-19 has shrunk by billions of dollars a year. Forced to rebuild th...

Core News & Articles
Benzinga Market Summary: Merck Beats Q2 Re...
07/30/2024 15:16:42

merck-exec-says-targeting-next-years-rsv-season-in-us-for-rsv-antibody
Merck Exec Says Targeting Next Year's RSV ...
07/30/2024 14:13:21

- Conf Call

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

08/05/2024 Marinus Pharmaceuticals, Inc. (MRNS)

NEW CASE INVESTIGATION

Ooma Inc (OOMA) AnaptysBio Inc (ANAB)